GenomeKey is dedicated to revolutionizing sepsis treatment by developing a next-generation diagnostic device that significantly reduces the time to identify effective antibiotics from days to mere hours. By leveraging advanced machine learning and DNA sequencing technologies, we aim to enhance patient outcomes while conserving vital antibiotics for critical cases, ultimately saving lives and healthcare costs.